Biofluid biomarkers in Alzheimer’s disease and other neurodegenerative dementias

Improved technologies facilitate the detection of molecules linked to neurodegenerative brain changes at very low concentrations in the blood, complementing the clinical evaluation of suspected neurodegenerative disease.